Piper Sandler Maintains Neutral on Staar Surgical, Raises Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Matt O'Brien has maintained a Neutral rating on Staar Surgical (NASDAQ:STAA) while raising the price target from $33 to $40.
May 08, 2024 | 3:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler maintains a Neutral rating on Staar Surgical but increases the price target from $33 to $40.
The increase in price target by Piper Sandler from $33 to $40, while maintaining a Neutral rating, suggests a positive outlook on Staar Surgical's stock value in the short term. This adjustment reflects an expectation of stronger performance or favorable market conditions for Staar Surgical, potentially leading to increased investor interest and a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100